Featured Story

QuantuMDx teams up with Swiss nonprofit to develop handheld TB test

QuantuMDx is teaming up with a Swiss nonprofit organization to develop its handheld test for tuberculosis, building momentum for a full commercial rollout of its innovative diagnostic tool.

Nanosphere reels in $18.4M in stock sale

Molecular diagnostics developer Nanosphere reeled in $18.4 million in a stock sale with the proceeds slotted to be used for general corporate purposes and working capital.

'See-through' sensors for the brain are transparent to imaging diagnostics

Researchers at the University of Wisconsin-Madison have come up with an implantable sensor so thin that scientists studying the brain can see through it using a wide range of imaging technologies.

FDA grants bioMérieux emergency authorization for one-hour Ebola Dx

BioFire, a subsidiary of French diagnostics outfit bioMérieux, was granted emergency authorization from the FDA for two of its Ebola tests.

Johns Hopkins scientists develop real-time diagnostic system for drug-resistant bacteria

Amid the rise of antibiotic-resistant superbugs in hospital systems and facilities, scientists at Johns Hopkins are developing a real-time tracking system that could quickly diagnose and monitor antibiotic-resistant bacterial infections.


From Our Sister Sites


With several companies now expediting Ebola vaccines in an attempt to halt the spread of the deadly virus, Novavax has jumped in the race, announcing that it's using its nanoparticle vaccine technology to advance a candidate of its own.


GE Healthcare has opened its first health tech startup campus at its Finland headquarters in Helsinki. It's already home to 20 health tech startups working on wireless technologies, sensors, apps and cloud services to improve healthcare.